Immature platelet fraction measured on the Sysmex XN hemocytometer predicts thrombopoietic recovery after autologous stem cell transplantation

European Journal of Haematology

Volumn 93, Issue 2, 2014, Pages 150-156

  van der Linden, Noreen ^a   Klinkenberg, Lieke J J ^a   Meex, Steven J R ^a   Beckers, Erik A M ^a   de Wit, Norbert C J ^a   Prinzen, Lenneke ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Immature platelet fraction; Platelets; Stem cell transplantation; Thrombopoiesis; Transfusion

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ADULT; ANALYZER; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL COUNTING CHAMBER; CLINICAL ARTICLE; FEMALE; FOLLICULAR LYMPHOMA; HEMATOLOGICAL PARAMETERS; HODGKIN DISEASE; HUMAN; MALE; MULTIPLE MYELOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPHYLAXIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS; ADVERSE EFFECTS; AGED; AUTOTRANSPLANTATION; CELL DIFFERENTIATION; CYTOLOGY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LABORATORY AUTOMATION; MIDDLE AGED; PATHOLOGY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TIME FACTOR;

ADULT; AGED; AUTOMATION, LABORATORY; BLOOD PLATELETS; CELL DIFFERENTIATION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION; REFERENCE VALUES; ROC CURVE; THROMBOCYTOPENIA; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84904291072     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12319     Document Type: Article

References (45)

1. Kaushansky K. Determinants of platelet number and regulation of thrombopoiesis. Hematology Am Soc Hematol Educ Program 2009;2009:147-52.
2. Abe Y, Wada H, Tomatsu H, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006;118:463-9.
3. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93-9.
4. Strauss G, Vollert C, von Stackelberg A, Weimann A, Gaedicke G, Schulze H. Immature platelet count: a simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia. Pediatr Blood Cancer 2011;57:641-7.
5. Ingram M, Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol 1969;17:225-9.
6. Karpatkin S. Human platelet senescence. Annu Rev Med 1972;23:101-28.
7. Briggs C, Hart D, Kunka S, Oguni S, Machin SJ. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med 2006;16:101-9.
8. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990;75:116-21.
9. Lee LG, Chen CH, Chiu LA. Thiazole orange: a new dye for reticulocyte analysis. Cytometry 1986;7:508-17.
10. Jimenez MM, Guedan MJ, Martin LM, Campos JA, Martinez IR, Vilella CT. Measurement of reticulated platelets by simple flow cytometry: an indirect thrombocytopoietic marker. Eur J Intern Med 2006;17:541-4.
11. Ault KA. Flow cytometric measurement of platelet function and reticulated platelets. Ann N Y Acad Sci 1993;677:293-308.
12. Sakakura M, Wada H, Abe Y, Nishioka J, Tomatsu H, Hamaguchi Y, Oguni S, Shiku H, Nobori T. Usefulness of measurement of reticulated platelets for diagnosis of idiopathic thrombocytopenic purpura. Clin Appl Thromb Hemost 2005;11:253-61.
13. Goncalo AP, Barbosa IL, Campilho F, Campos A, Mendes C. Predictive value of immature reticulocyte and platelet fractions in hematopoietic recovery of allograft patients. Transplant Proc 2011;43:241-3.
14. Takami A, Shibayama M, Orito M, Omote M, Okumura H, Yamashita T, Shimadoi S, Yoshida T, Nakao S, Asakura H. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation. Bone Marrow Transplant 2007;39:501-7.
15. Zucker ML, Murphy CA, Rachel JM, Martinez GA, Abhyankar S, McGuirk JP, Reid KJ, Plapp FV. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol 2006;12:125-30.
16. Martinelli G, Merlo P, Fantasia R, Gioia F, Crovetti G. Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation. Transfus Apher Sci 2009;40:175-81.
17. Michur H, Maslanka K, Szczepinski A, Marianska B. Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation. Int J Lab Hematol 2008;30:519-25.
18. Chaoui D, Chakroun T, Robert F, et al. Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy. Transfusion 2005;45:766-72.
19. Richards EM, Jestice HK, Mahendra P, Scott MA, Marcus RE, Baglin TP. Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: implications for marrow reconstitution and the use of thrombopoietin. Bone Marrow Transplant 1996;17:1029-33.
20. Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol 2004;41(1 Suppl 1):93-100.
21. Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004;18:153-67.
22. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;66:1105-9.
23. Estcourt LJ, Stanworth SJ, Murphy MF. Platelet transfusions for patients with haematological malignancies: who needs them? Br J Haematol 2011;154:425-40.
24. Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1519-38.
25. British Committee for Standards in Haematology BTTF. Guidelines for the use of platelet transfusions. Br J Haematol 2003;122:10-23.
26. Wandt H, Schaefer-Eckart K, Wendelin K, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012;380:1309-16.
27. Shinjo K, Takeshita A, Nakamura S, Naitoh K, Yanagi M, Tobita T, Ohnishi K, Ohno R. Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia. Leukemia 1998;12:295-300.
28. Yamaoka G, Kubota Y, Nomura T, Inage T, Arai T, Kitanaka A, Saigo K, Iseki K, Baba N, Taminato T. The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation. Int J Lab Hematol 2010;32(6 Pt 1):e208-16.
29. Wang C, Smith BR, Ault KA, Rinder HM. Reticulated platelets predict platelet count recovery following chemotherapy. Transfusion 2002;42:368-74.
30. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
31. Briggs C, Longair I, Kumar P, Singh D, Machin SJ. Performance evaluation of the Sysmex haematology XN modular system. J Clin Pathol 2012;65:1024-30.
32. Meintker L, Haimerl M, Ringwald J, Krause SW. Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients. Clin Chem Lab Med 2013;51:2125-31.
33. CBO. Richtlijn bloedtransfusie. Utrecht, the Netherlands: CBO, 2011.
34. Sanquin. Bloedwijzer deel 1; Erytrocyten, Trombocyten, Vers bevroren plasma. Amsterdam, the Netherlands: Sanquin 2013.
35. Burdick RK. Chapter 5.2. The balanced two-fold nested random model. In: Burdick RK, Graybill FA, eds. Confidence Intervals on Variance Components. New York, USA: Marcel Dekker; 1992:79-91.
36. Fraser CG. Reference change values. Clin Chem Lab Med 2012;50:807-12.
37. Harris EK, Yasaka T. On the calculation of a "reference change" for comparing two consecutive measurements. Clin Chem 1983;29:25-30.
38. Emir B, Wieand S, Su JQ, Cha S. Analysis of repeated markers used to predict progression of cancer. Stat Med 1998;17:2563-78.
39. Cid J, Lozano M. Platelet dose for prophylactic platelet transfusions. Expert Rev Hematol 2010;3:397-400.
40. Ricos C, Iglesias N, Garcia-Lario JV, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007;44(Pt 4):343-52.
41. Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;1(Pt 1):8-12.
42. Psaila B, Bussel JB, Frelinger AL, Babula B, Linden MD, Li Y, Barnard MR, Tate C, Feldman EJ, Michelson AD. Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. J Thromb Haemost 2011;9:2302-10.
43. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995;85:2720-30.
44. Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE. Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion. Transfusion 2013;53:1201-4.
45. Saigo K, Sakota Y, Masuda Y, et al. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients. Transfus Apher Sci 2008;38:127-32.